S. Veld

发表

The simultaneous isolation of multiple high and low frequent T-cell populations from donor peripheral blood mononuclear cells using the major histocompatibility complex I-Streptamer isolation technology.

Christian Stemberger, M. Kester, J. Falkenburg, 2018, Cytotherapy.

High Mutation Frequency of the PIGA Gene in T Cells Results in Reconstitution of GPI Anchor−/CD52− T Cells That Can Give Early Immune Protection after Alemtuzumab-Based T Cell–Depleted Allogeneic Stem Cell Transplantation

H. Veelken, P. A. von dem Borne, I. Jedema, 2018, The Journal of Immunology.

Effect of alemtuzumab-based T-cell depletion on graft compositional change in vitro and immune reconstitution early after allogeneic stem cell transplantation.

J. Falkenburg, J. Zwaginga, H. Veelken, 2020, Cytotherapy.

CD4 Donor Lymphocyte Infusion Can Cause Conversion of Chimerism Without GVHD by Inducing Immune Responses Targeting Minor Histocompatibility Antigens in HLA Class II

J. Falkenburg, M. Griffioen, J. Zwaginga, 2018, Front. Immunol..

Generation and infusion of multi-antigen-specific T cells to prevent complications early after T-cell depleted allogeneic stem cell transplantation—a phase I/II study

H. Einsele, L. Germeroth, J. Zwaginga, 2019, Leukemia.

Rapid Generation of Marker-Free P. falciparum Fluorescent Reporter Lines Using Modified CRISPR/Cas9 Constructs and Selection Protocol

C. Janse, B. Franke-Fayard, J. Ramesar, 2016, PloS one.

Competitive repopulation and allo-immunological pressure determine chimerism kinetics after T-cell depleted allogeneic stem cell transplantation and donor lymphocyte infusions.

H. Veelken, P. A. von dem Borne, L. D. de Wreede, 2022, Transplantation and cellular therapy.

CMV seronegative donors: Effect on clinical severity of CMV infection and reconstitution of CMV-specific immunity.

W. Marijt, L. D. de Wreede, I. Jedema, 2018, Transplant immunology.

HA-1H T-Cell Receptor Gene Transfer to Redirect Virus-Specific T Cells for Treatment of Hematological Malignancies After Allogeneic Stem Cell Transplantation: A Phase 1 Clinical Study

M. V. van Loenen, R. Hagedoorn, R. de Boer, 2020, Frontiers in Immunology.

A Minority of T Cells Recognizing Tumor-Associated Antigens Presented in Self-HLA Can Provoke Anti-Tumor Reactivity.

Christian Stemberger, H. Einsele, J. Falkenburg, 2020, Blood.

Effective Treatment of Refractory CMV Reactivation After Allogeneic Stem Cell Transplantation With In Vitro-generated CMV pp65-specific CD8+ T-cell Lines

A. Lankester, P. A. von dem Borne, S. Kruithof, 2012, Journal of immunotherapy.

Loss of the GPI‐anchor in B‐lymphoblastic leukemia by epigenetic downregulation of PIGH expression

J. Neefjes, M. Griffioen, Xiaohang Qiao, 2018, American journal of hematology.

What does cell therapy manufacturing cost? A framework and methodology to facilitate academic and other small-scale cell therapy manufacturing costings.

Jarno Hoekman, Marcel H N Hoefnagel, Gerty Schreibelt, 2020, Cytotherapy.

Tracking the progeny of adoptively transferred virus-specific T cells in patients posttransplant using TCR sequencing

H. Einsele, L. Germeroth, C. V. van Bergen, 2022, Blood advances.